Novavax

During the second quarter, Novavax continued executing against its four key priorities for the remainder of 2024. Take a look at our second quarter 2024 financial results and operational highlights: https://lnkd.in/ehApGqdt

Novavax's conference call to discuss second quarter 2024 financial results and operational highlights is starting at 8:30 a.m. ET. Learn how you can join the call: https://lnkd.in/eUsnQkrV

August is National Immunization Awareness Month! Here at Novavax, our focus is on developing life-saving vaccines to fight infectious diseases. Find #vaccination resources to learn more and share with your network from the Centers for Disease Control and Prevention: https://lnkd.in/erfttS8 #vaccineswork #NIAM

Novavax's conference call to discuss second quarter 2024 financial results and operational highlights is August 8 at 8:30 a.m. ET. Learn how you can join the call: https://lnkd.in/eD966Dqh

“We need to rebuild confidence in the value and significance of a #COVID vaccine.” -Novavax President and COO, John Trizzino. Novavax was honored to attend Premier Inc.’s Breakthroughs ‘24 last week to discuss the future of vaccination. Thank you to all who joined! Learn more about Novavax here: https://www.novavax.com/

We are proud to share Novavax’s involvement in Citeline’s Navigating Clinical Trial Success: Biotech Lessons Learned roundtable. Learn from our Vice President of Clinical Development, Vivek Shinde MD, MPH, and other experts featured in the publication: https://lnkd.in/eUTpS98q

At Novavax, we're collaborating to help build a future free from the grip of malaria. Learn more: https://lnkd.in/eidH9A2E

Novavax is pleased to announce a publication in Vaccines as part of the special issue, “Knowledge, Attitudes, Beliefs and Hesitancy towards COVID-19 Vaccination and Booster Doses.” Learn more: https://lnkd.in/gUqYnxmx

On July 24 at 12:30 PM, Premier Inc.'s Chief Commercial Officer Andy Brailo will be interviewing our President and COO John Trizzino during a live stream of Premier’s Breakthroughs '24 conference. Their conversation will highlight Novavax as a Premier contracted supplier.

Malaria is one of the deadliest diseases in history and so common that a child under five years of age dies from malaria nearly every minute of every day. Learn more: https://lnkd.in/eidH9A2E